These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31648716)

  • 1. Public Reporting for Cardiac Procedures: Is the Juice Worth the Squeeze?
    Kataruka A; Doll JA; Hira RS
    J Am Coll Cardiol; 2019 Oct; 74(17):2218. PubMed ID: 31648716
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost awareness decreases total percutaneous coronary intervention procedural cost: The SHOPPING (Show How Options in Price for Procedures Can Be Influenced Greatly) trial.
    Asher E; Mansour J; Wheeler A; Kendrick D; Cunningham M; Parikh S; Zidar D; Harford T; Simon DI; Kashyap VS
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1207-1212. PubMed ID: 27862875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply: Public Reporting for Cardiac Procedures: Is the Juice Worth the Squeeze?
    O'Brien CW; Wadhera RK; Yeh RW
    J Am Coll Cardiol; 2019 Oct; 74(17):2219. PubMed ID: 31648717
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivalirudin in the cardiac cath lab: streamlining the percutaneous coronary intervention experience.
    Schussler JM
    J Invasive Cardiol; 2004 Dec; 16 Suppl G():26-8. PubMed ID: 23570206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and Physician Perspectives on Public Reporting of Mortality Ratings for Percutaneous Coronary Intervention in New York State.
    Fernandez G; Narins CR; Bruckel J; Ayers B; Ling FS
    Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28893831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striking a balance between quality and cost in PCI.
    Kimmelstiel C; Udelson JE
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1213-1214. PubMed ID: 28612419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Survey of Interventional Cardiologists' Attitudes and Beliefs About Public Reporting of Percutaneous Coronary Intervention.
    Blumenthal DM; Valsdottir LR; Zhao Y; Shen C; Kirtane AJ; Pinto DS; Resnic FS; Maddox KEJ; Wasfy JH; Mehran R; Rosenfield K; Yeh RW
    JAMA Cardiol; 2018 Jul; 3(7):629-634. PubMed ID: 29801157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of transradial percutaneous coronary intervention.
    Amin AP; House JA; Safley DM; Chhatriwalla AK; Giersiefen H; Bremer A; Hamon M; Baklanov DV; Aluko A; Wohns D; Mathias DW; Applegate RA; Cohen DJ; Marso SP
    JACC Cardiovasc Interv; 2013 Aug; 6(8):827-34. PubMed ID: 23871512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining operative mortality: Impact on outcome reporting.
    Maximus S; Milliken JC; Danielsen B; Khan J; Shemin R; Carey JS
    J Thorac Cardiovasc Surg; 2016 Apr; 151(4):1101-7. PubMed ID: 26876420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving the quality of percutaneous revascularisation in patients with multivessel disease in Australia: cost-effectiveness, public health implications, and budget impact of FFR-guided PCI.
    Siebert U; Arvandi M; Gothe RM; Bornschein B; Eccleston D; Walters DL; Rankin J; De Bruyne B; Fearon WF; Pijls NH; Harper R
    Heart Lung Circ; 2014 Jun; 23(6):527-33. PubMed ID: 24560401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registry.
    Ariyaratne TV; Ademi Z; Duffy SJ; Andrianopoulos N; Billah B; Brennan AL; New G; Black A; Ajani AE; Clark DJ; Yan BP; Yap CH; Reid CM
    Int J Cardiol; 2013 Oct; 168(3):2783-90. PubMed ID: 23643437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are public relations programs worth what they cost?
    STEARNS RL
    J Am Med Assoc; 1955 Feb; 157(7):591-5. PubMed ID: 13232983
    [No Abstract]   [Full Text] [Related]  

  • 14. Public Reporting of Percutaneous Coronary Intervention Outcomes: Institutional Costs and Physician Burden.
    Wadhera RK; O'Brien CW; Joynt Maddox KE; Ho KKL; Pinto DS; Resnic FS; Shah PB; Yeh RW
    J Am Coll Cardiol; 2019 May; 73(20):2604-2608. PubMed ID: 30885686
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost of elective percutaneous coronary intervention in Malaysia: a multicentre cross-sectional costing study.
    Lee KY; Ong TK; Low EV; Liow SY; Anchah L; Hamzah S; Liew HB; Ali RM; Ismail O; Ahmad WAW; Said MA; Dahlui M
    BMJ Open; 2017 May; 7(5):e014307. PubMed ID: 28552843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costs Associated With Access Site and Same-Day Discharge Among Medicare Beneficiaries Undergoing Percutaneous Coronary Intervention: An Evaluation of the Current Percutaneous Coronary Intervention Care Pathways in the United States.
    Amin AP; Patterson M; House JA; Giersiefen H; Spertus JA; Baklanov DV; Chhatriwalla AK; Safley DM; Cohen DJ; Rao SV; Marso SP
    JACC Cardiovasc Interv; 2017 Feb; 10(4):342-351. PubMed ID: 28231901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends in Coronary Angiography and Percutaneous Coronary Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program.
    Waldo SW; Gokhale M; O'Donnell CI; Plomondon ME; Valle JA; Armstrong EJ; Schofield R; Fihn SD; Maddox TM
    JACC Cardiovasc Interv; 2018 May; 11(9):879-888. PubMed ID: 29747919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Excluding Shock Patients on Hospital and Physician Risk-Adjusted Mortality Rates for Percutaneous Coronary Interventions: The Implications for Public Reporting.
    Hannan EL; Zhong Y; Cozzens K; Gesten F; Friedrich M; Berger PB; Jacobs AK; Walford G; Ling FS; Venditti FJ; King SB
    JACC Cardiovasc Interv; 2017 Feb; 10(3):224-231. PubMed ID: 28183462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Patients With Cardiac Arrest Complicating Myocardial Infarction in New York Before and After Public Reporting Policy Changes.
    Strom JB; McCabe JM; Waldo SW; Pinto DS; Kennedy KF; Feldman DN; Yeh RW
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28495895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public Reporting of Percutaneous Coronary Intervention Outcomes: Moving Beyond the Status Quo.
    Wadhera RK; Joynt Maddox KE; Yeh RW; Bhatt DL
    JAMA Cardiol; 2018 Jul; 3(7):635-640. PubMed ID: 29800962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.